JON PRAIRIE: Open Payments
NPI 1376090266 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 6 payments from 5 companies in 2025. Trend: 2023 $23 · 2024 $0 · 2025 $547
Food & beverage: $448Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $224 |
| E.R. Squibb & Sons, L.L.C. | 1 | $109 |
| PharmaEssentia USA Corporation | 1 | $108 |
| Janssen Biotech, Inc. | 1 | $89 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: REBLOZYL, BESREMI, KISQALI.
Industry payments across IN — which companies pay providers there.
